Skip to main content
Focused investors/Bill Ackman

Bill Ackman - Pershing Square Capital Management

As of Q2 2026, Bill Ackman reported 14 long-equity positions worth $19.47B in aggregate.

Copy-investor backtest

Latest quarter
+1.96%
1-year
+15.11%
3-year
+41.35%
5-year
+50.23%
3-year vs S&P 500
-31.89%
5-year vs S&P 500
-23.45%
5-year top 5
+52.69%

Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.

Get email alerts when Bill Ackman files a new 13F — sign in or create a free account.

Updated 2026-06-06 from SEC 13F data.

Live quotes available for 5 of 8 rows. Rows without a quote are marked unavailable.

1VRXVALEANT PHARMACEUTICALS INTL24.90%-19,473,933$3.47BNo quoteNo quote
2APDAIR PRODS & CHEMS INC18.79%-20,549,076$2.62B$127.58No quote
3CPCANADIAN PAC RY LTD14.35%-13,940,890$2B$143.57No quote
4MDLZMONDELEZ INTL INC13.02%New43,366,342$1.82B$41.87No quote
5ZTSZOETIS INC12.35%-41,823,145$1.72B$41.18No quote
6QSRRESTAURANT BRANDS INTL INC9.79%-38,003,984$1.37B$35.92No quote
7PAHPLATFORM SPECIALTY PRODS COR3.88%-42,737,394$540.63MNo quoteNo quote
8HHCHOWARD HUGHES CORP2.93%-3,568,017$409.39MNo quoteNo quote